USE OF A PSMA ANTIGEN AND A PRAME ANTIGEN FOR THE MANUFACTURE OF MEDICAMENTS FOR TREATMENT OF PANCREATIC CANCER AND IMMUNOGENIC COMPOSITIONS COMPRISING A PSMA ANTIGEN AND A PRAME ANTIGEN FOR THE TREATMENT OF PANCREATIC CANCER
Disclosed herein are methods and compositions for inducing an immune response against various combinations of tumor-associated antigens, which can promote effective immunologic intervention in pathogenic processes. Embodiments of the invention disclosed herein are directed to the use of effective combinations of TuAAs for the immunotherapy of patients with various types of cancer. Both immunogenic compositions for inducing an immune response to these combinations of antigens and methods for their use are disclosed.
